Medicine & Health
Updates every hour. Last Updated: 7-Jun-2025 19:09 ET (7-Jun-2025 23:09 GMT/UTC)
Lessons learned from the COVID-19 crisis: improving protection through early response, rapid tracking and impact monitoring
Institut PasteurPeer-Reviewed Publication
- Journal
- BMC Global and Public Health
Breaking new ground in health care: Setting the standard for XR clinical research with the RATE-XR guideline
JMIR PublicationsPeer-Reviewed Publication
- Journal
- Journal of Medical Internet Research
New research reveals two types of fatty liver disease
Karolinska InstitutetPeer-Reviewed Publication
Researchers at Karolinska Institutet and the University of Gothenburg have identified two types of metabolic-associated fatty liver disease – a liver-specific type and a systemic type that affects other organs and tissues. The discovery could lead to improved diagnosis and treatment of this growing patient group. Two studies are published back-to-back in Nature Medicine.
- Journal
- Nature Medicine
Genetic code deploys cancer mafia, new targeted drug gives them an offer they can’t refuse
Virginia Commonwealth UniversityPeer-Reviewed Publication
A group of scientists at VCU Massey Comprehensive Cancer Center has revealed a new genetic code that acts like a cancer ringleader, recruiting and deploying a gang of tumor cells to incite a biological turf war by invading healthy organs and overpowering the normal cells. This discovery — published today, Dec. 9, in Nature Biotechnology — could unveil an entirely different understanding of the origins of cancer within the body, as well as offer groundbreaking insight into new treatment strategies that could target the growth of tumors in their earliest stages. A group of scientists at VCU Massey Comprehensive Cancer Center has revealed a new genetic code that acts like a cancer ringleader, recruiting and deploying a gang of tumor cells to incite a biological turf war by invading healthy organs and overpowering the normal cells. This discovery — published today, Dec. 9, in Nature Biotechnology — could unveil an entirely different understanding of the origins of cancer within the body, as well as offer groundbreaking insight into new treatment strategies that could target the growth of tumors in their earliest stages.
- Journal
- Nature Biotechnology
- Funder
- VCU Massey Comprehensive Cancer Center, VCU School of Medicine, Adenoid Cystic Carcinoma Research Foundation, Swiss Cancer League, Seeds of Science, UAMS, SNSF, Tina's Wish Foundation, FIS, Josef Steiner Cancer Research Foundation, Fundação Champalimaud, Novo Nordisk, Lundbeck Foundation, NIH/National Cancer Institute, NIH/National Institutes of Health, Dubrow Fund, Bucks County Board of Associates, KU Cancer Center, Kansas Institute for Precision Medicine
Are women really more prone to ACL injuries? New study challenges common claims
University of BathPeer-Reviewed Publication
- Journal
- British Journal of Sports Medicine
A new explanation for dangerous atherosclerotic plaques in type 2 diabetes
Lund UniversityPeer-Reviewed Publication
People with type 2 diabetes have a higher risk of developing cardiovascular disease and dying prematurely due to atherosclerosis. A research team at Lund University in Sweden has now identified molecular mechanisms that may explain the increased risk. Their discovery may lead to more accurate treatments for patients with atherosclerosis and type 2 diabetes in the future.
- Journal
- Nature Communications